NORD drafts comments on Senate Health, Education, Labor and Pensions committee’s discussion on FDA Safety and Landmark Advancements Act
Published: May 22, 2022
Tagged in: FDA’s Accelerated Approval Pathway, Expanded Access, Orphan Drug Act
For decades, NORD has pursued federal and state policies that will change the lives of Americans impacted by rare diseases for the better. NORD’s work can be viewed below. This page is updated daily to provide timely information. Please contact us if you have questions or need additional information.
NORD drafts comments on Senate Health, Education, Labor and Pensions committee’s discussion on FDA Safety and Landmark Advancements Act
Published: May 22, 2022
Tagged in: FDA’s Accelerated Approval Pathway, Expanded Access, Orphan Drug Act
Coalition principles for access to unapproved therapies
Published: May 2, 2017
Tagged in: Expanded Access, Access to Innovative Medicines and Therapies
